Theravance (THRX)

Add to Watchlists Create an Alert
25.32 -2.36  -8.53% NASDAQ Jul 23, 5:00PM BATS Real time Currency in USD
View Full Chart
THRX Price Chart
View All Events

THRX Events

Date Type Description
05/06/2014 17:00 EDT Misc Q1 2014 Theravance, Inc. Earnings Conference Call
05/06/2014 Earnings Q1 2014 Theravance, Inc. Earnings Results. Estimate: -0.53.
04/01/2014 Misc Theravance Appoints Kevin Kwok, Head of Talent Acquisition and Strategy
02/06/2014 05:00 EST Misc Theravance to Report Fourth Quarter and Full Year 2013 Conference Call
02/06/2014 Earnings Theravance to Report Fourth Quarter and Full Year 2013 Financial Results. Estimate: -0.39.
10/24/2013 17:00 EDT Misc Theravance Third Quarter 2013 Financial Results Conference Call
10/24/2013 Earnings Theravance to Report Third Quarter 2013 Financial Results on October 24, 2013. Estimate: -0.79.
07/25/2013 17:00 EDT Misc Theravance, Inc. Second Quarter Earnings Conference Call
07/25/2013 Earnings Theravance to Report Second Quarter 2013 Financial Results on July 25, 2013. Estimate: -0.59.
View All Performance Charts

THRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Theravance is down 18.23% over the last year vs S&P 500 Total Return up 19.65%, Theravance Biopharma up N/A, and GlaxoSmithKline up 1.28%.

Get Quote for

PDF Report for THRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download THRX Pro Report PDF
Advertisement

Portfolio Strategies Featuring THRX

Did Theravance make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

THRX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.theravance.com
  • IR Website: http://investor.theravance.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Theravance Inc., is a biopharmaceutical company with a pipeline of internally discovered product candidates and collaborations with pharmaceutical companies.

THRX Excel Add-In Codes

  • Name: =YCI("THRX","name")
  • Description: =YCI("THRX","description")
  • Sector: =YCI("THRX","sector")
  • Industry: =YCI("THRX","industry")
  • Est. Current Fiscal Year End: =YCI("THRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.